Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry May 16, 2023 06:00AM
Senda Biosciences Announces Close of $123 Million Series C Financing Aug 16, 2022 07:00AM
Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer Jun 7, 2022 08:00AM
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT Feb 15, 2022 10:05AM
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology Jan 26, 2022 09:31AM


Oct 20, 2021 07:00AM Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors
Oct 13, 2021 10:11AM Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change